Searchable abstracts of presentations at key conferences in endocrinology

ea0032p470 | Diabetes | ECE2013

Monitoring and control of blood glucose levels in patients with inefficiently controlled insulin-treated diabetes mellitus through the utilization of an on-line telemonitoring system

Fountoulakis Stelios , Papanastasiou Labrini , Marakaki Chrisanthi , Anastasakou Marina , Piaditis George

Introduction: Our goal was to monitor and control the blood glucose levels in inefficiently controlled insulin-treated patients with diabetes mellitus (DM). The target was to achieve an early detection of DM deregulation, to maintain accepted HbA1c levels through active intervention and to minimize the outpatient department visits.Description of methods/design: Twenty-six insulin-treated type 1 and 2 DM patients were enrolled (mean age 61.42±14.5 ye...

ea0035p475 | Diabetes therapy | ECE2014

Improvement of HbA1c is blunted following discontinuation of an on-line telemonitoring system, in patients with inefficiently controlled insulin-treated diabetes mellitus

Fountoulakis Stelios , Papanastasiou Labrini , Malliopoulos Dimosthenis , Marakaki Chrisanthi , Markou Athina , Kounadi Theodora , Piaditis George

Aim: Primary goal was to determine whether the improvement of HbA1c, observed in inefficiently insulin-treated diabetes mellitus (DM) patients on a telemonitoring system, had a lasting effect following its discontinuation.Methods: Forty-seven DM patients (mean age 56.15±15.86 years, mean BMI 29.44±6.69 kg/m2, mean HbA1c 9.9±2.62%) and 25 insulin-treated matched controls (mean age 56.16±20.11 years, mean BMI 27.6±5.18 k...

ea0032p46 | Adrenal cortex | ECE2013

Autonomous aldosterone secretion as a significant cause of arterial hypertension: the effectiveness of targeted therapy

Papanastasiou Labrini , Pappa Theodora , Fountoulakis Stelios , Tsounas Panagiotis , Markou Athina , Tsiavos Vaios , Anastasakou Marina , Marakaki Chrisanthi , Malliopoulos Dimosthenis , Kounadi Theodora , Piaditis George

Introduction: The prevalence of autonomous aldosterone secretion (AAS) in hypertensive subjects varies due to the use of various suppression tests and cut-off values. Our aim was to evaluate the prevalence of AAS in hypertensive subjects and test the anti-hypertensive effect of targeted treatment of the renin angiotensin II aldosterone system (RAAS) in AAS subjects.Description of methods/design: We investigated 336 hypertensive subjects with and without ...